Akceso’s ‘Evidence-based Asset Valuation’ methodology
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
Joan Gibert
External Reference Pricing may have negative effects globally? – research article in Frontiers
This 5 years of research explores how external reference pricing (ERP, or also called as IRP – International Reference Pricing) is used to set pharmaceutical prices to improve affordability, but how its application may have negative consequences on patient access across certain countries.
